FDA accepts Beren Therapeutics’ NDA for Niemann-Pick disease
The submission includes data indicating a meaningful survival benefit for infantile-onset NPC patients treated with adrabetadex.
Drug Development
AstraZeneca’s Calquence plus venetoclax gains approval in US to treat CLL
Roche receives FDA acceptance for giredestrant combo NDA
Boehringer Ingelheim and NIPER sign MoU on pharmaceutical research
Syngene and VivaMed collaborate on therapeutic programmes
Novartis enters licensing agreement with UNP for peptide therapeutics
MSD and Mayo Clinic team up to advance AI in drug development
Evogene and QUT partner on AI-based cancer therapies
